More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications.…
GLP-1 medications, such as semaglutide (Ozempic, Wegovy, and Rybelsus), commonly prescribed for diabetes and obesity may also be linked to…
Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to meaningful weight loss. However, the…
Experts from UCL and the University of Cambridge warn that many people prescribed newer weight loss medications may not be…
A new real-world comparison finds that bariatric surgery leads to dramatically more weight loss than popular injectable medications. After two…
A new study led by a researcher at University College London (UCL) has found that the anti-obesity medication semaglutide (Ozempic…
A promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and…
A major study from Cleveland Clinic found that people with both obesity and type 2 diabetes who had weight-loss surgery…
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna,…
Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of…